Aggregate prepayments totaling US$50 million completed under agreement with lenders are expected to reduce annual cash interest expense by US$6.5 million SMITHS FALLS, Ontario — September 15, 2025 — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives,…
Continue ReadingSleek portability. Precision engineering. Premium performance. Four exciting new colors TUTTLINGEN, Germany (September 9, 2025) – STORZ & BICKEL GmbH (“STORZ & BICKEL” or the “Company”), a world-leading manufacturer of high-end, medically certified cannabis vaporizers and a subsidiary of Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC), today unveiled the VEAZY— an accessible new addition to…
Continue Reading• Shareholders are reminded to submit their vote as soon as possible, and well in advance of the proxy voting deadline on Wednesday, September 24, 2025 at 1:00 p.m. ET to avoid Canopy incurring additional costs • Questions or need voting assistance? Contact Laurel Hill Advisory Group toll free at 1-877-452-7184, or by email at…
Continue ReadingSMITHS FALLS, ON. August 29, 2025 — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, announced today that the Company has established a new at-the-market equity program (the “ATM Program”) that allows Canopy Growth to issue and…
Continue ReadingVoting is important and easy; shareholders are urged to vote today to help the Company avoid incurring additional costs. Canopy Growth shareholders with a 16-digit control number can vote online at http://proxyvote.com, and by phone at 1-800-474-7493. For more information, shareholders should contact Canopy Growth’s strategic shareholder advisor and proxy solicitation agent, Laurel Hill Advisory Group, at 1-877-452-7184 (1‑416‑304‑0211…
Continue ReadingCanada adult-use cannabis Q1 FY2026 net revenue increased 43% year-over-year, benefiting from increased distribution and strong consumer demand for new products, including Claybourne infused pre-roll joints Company has achieved $17MM of planned $20MM annualized savings target since March 1, 2025; SG&A expenses down 21% year-over-year in Q1 FY2026 compared to Q1 FY2025 Supply chain improvements…
Continue ReadingLaunch complements existing Tweed and Spectrum Therapeutics product portfolio SMITHS FALLS, ON. August 5, 2025 — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, has introduced its Canadian-grown 7ACRES brand in Australia, expanding the Company’s medical cannabis…
Continue ReadingAppointment reinforces Canopy Growth’s focus on accelerating growth in Europe and delivering on its Global Medical strategy SMITHS FALLS, ON. July 31, 2025 — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, today announced the appointment of Miles Worne…
Continue ReadingThis news release constitutes a “designated news release” for the purposes of Canopy Growth’s prospectus supplement dated February 28, 2025 to its short form base shelf prospectus dated June 5, 2024. SMITHS FALLS, ON. July 29, 2025 — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated…
Continue ReadingSmiths Falls, ON, July 25, 2025 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NASDAQ:CGC) will release its financial results for the first quarter fiscal year 2026 ended June 30, 2025 before financial markets open on August 8, 2025. Following the release of its first quarter fiscal year 2026 financial results, Canopy Growth…
Continue Reading